de Oliveira Daniele V, Van Der Sand Sueli T
Laboratório de Microbiologia Ambiental, Departamento de Microbiologia, Imunologia e Parasitologia, Instituto de Ciências Básicas da Saúde, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.
Curr Microbiol. 2016 Jul;73(1):132-8. doi: 10.1007/s00284-016-1036-6. Epub 2016 Apr 12.
Some bacteria from the Enterobacteriaceae family are showing a significant capability to disseminate β-lactams resistance mechanisms among them, and these same mechanisms can be carried out from the hospital environment to superficial water. The aim of this study was to evaluate different phenotypic methods for the detection β-lactamases production by enterobacteria isolated from the anthropogenic environment: hospital wastewater and from a stream that cross the city of Porto Alegre. The applied tests were the modified Hodge test (MHT) and phenotypic tests with the following inhibitors: carbapenemase-phenylboronic acid (APB), metallo-β-lactamase-EDTA, AmpC β-lactamase-cloxacillin, and the confirmatory test for extended-spectrum β-lactamase (ESBL)-clavulanic acid. For this evaluation, 131 isolates were initially subjected to antibiogram using the following antimicrobials: cefotaxime (30 µg), cefpodoxime (10 μg), ceftazidime (30 µg), ertapenem (10 μg), meropenem (10 μg), and aztreonam (30 μg). After this first screening, 62 isolates showed a profile resistance for at least one antimicrobial. These isolates were subjected to all phenotypic tests. Of those, 40 isolates were positive for at least one phenotypic test. In MHT test, one isolate was positive and five were with inconclusive results. The results achieved with the inhibitors are as follows: APB 25/40 positive strains; EDTA 8/40 positive strains; and with CLOXA 2/40 positive strains. ESBL production was observed for 34/40 strains. This assessment shows a high level of bacteria which can produce enzymes that inactivate β-lactams present in the different environment like the stream waters and from the hospital settings.
肠杆菌科的一些细菌显示出在它们之间传播β-内酰胺耐药机制的显著能力,并且这些相同的机制可以从医院环境传播到地表水。本研究的目的是评估从人为环境(医院废水和流经阿雷格里港市的一条溪流)分离出的肠杆菌产生β-内酰胺酶的不同表型检测方法。所应用的试验是改良 Hodge 试验(MHT)以及使用以下抑制剂的表型试验:碳青霉烯酶-苯硼酸(APB)、金属β-内酰胺酶-EDTA、AmpCβ-内酰胺酶-氯唑西林,以及超广谱β-内酰胺酶(ESBL)-克拉维酸的确证试验。为了进行此评估,最初对131株分离株使用以下抗菌药物进行药敏试验:头孢噻肟(30μg)、头孢泊肟(10μg)、头孢他啶(30μg)、厄他培南(10μg)、美罗培南(10μg)和氨曲南(30μg)。在首次筛选后,62株分离株对至少一种抗菌药物表现出耐药谱。这些分离株进行了所有表型试验。其中,40株分离株至少一项表型试验呈阳性。在MHT试验中,1株分离株呈阳性,5株结果不确定。使用抑制剂获得的结果如下:APB 25/40株阳性菌株;EDTA 8/40株阳性菌株;CLOXA 2/40株阳性菌株。观察到34/40株菌株产生ESBL。该评估表明,在诸如溪水和医院环境等不同环境中,能够产生使β-内酰胺失活的酶的细菌水平很高。